SAMSUNG PHARM. Co., LTD. (KRX:001360)

South Korea · Delayed Price · Currency is KRW

1,276.00

+26.00 (2.08%)

Last updated: Aug 24, 2026, 12:06 PM KST

-19.50% (1Y)

Market Cap	117.65B -21.3%
Revenue (ttm)	44.29B -1.9%
Net Income	12.71B +306.8%
EPS	n/a
Shares Out	94.12M
PE Ratio	9.26
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	233,506
Open	1,268.00
Previous Close	1,250.00
Day's Range	1,255.00 - 1,290.00
52-Week Range	1,140.00 - 2,320.00
Beta	0.73
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SAMSUNG PHARM. Co., LTD.

SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, enzyme, mixed vitamins, antibiotics, and others. The company also provides medicines for the digestive system, medicines for liver disorders, medicines for the circulation ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1929

Employees 240

Stock Exchange Korea Stock Exchange

Ticker Symbol 001360

Full Company Profile

Financial Performance

In 2024, SAMSUNG PHARM. Co., LTD.'s revenue was 44.29 billion, a decrease of -14.75% compared to the previous year's 51.96 billion. Earnings were 12.71 billion, a decrease of -48.77%.

Financial Statements